Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3616935
Max Phase: Preclinical
Molecular Formula: C48H83N13O9
Molecular Weight: 986.27
Molecule Type: Small molecule
Associated Items:
ID: ALA3616935
Max Phase: Preclinical
Molecular Formula: C48H83N13O9
Molecular Weight: 986.27
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(C)CCC(=O)N[C@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O
Standard InChI: InChI=1S/C48H83N13O9/c1-7-30(6)13-14-40(62)54-32(15-20-49)42(64)58-36-19-24-53-41(63)37(25-28(2)3)59-44(66)34(17-22-51)55-43(65)33(16-21-50)57-48(70)39(27-31-11-9-8-10-12-31)61-47(69)38(26-29(4)5)60-45(67)35(18-23-52)56-46(36)68/h8-12,28-30,32-39H,7,13-27,49-52H2,1-6H3,(H,53,63)(H,54,62)(H,55,65)(H,56,68)(H,57,70)(H,58,64)(H,59,66)(H,60,67)(H,61,69)/t30?,32-,33+,34+,35+,36+,37+,38+,39-/m1/s1
Standard InChI Key: WLGYJRVNVOHNEN-LSPXZINZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 986.27 | Molecular Weight (Monoisotopic): 985.6437 | AlogP: -2.06 | #Rotatable Bonds: 21 |
Polar Surface Area: 365.98 | Molecular Species: BASE | HBA: 13 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 10.15 | CX LogP: -3.46 | CX LogD: -11.83 |
Aromatic Rings: 1 | Heavy Atoms: 70 | QED Weighted: 0.06 | Np Likeness Score: 0.48 |
1. De Zoysa GH, Cameron AJ, Hegde VV, Raghothama S, Sarojini V.. (2015) Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides., 58 (2): [PMID:25495219] [10.1021/jm501084q] |
Source(1):